1. Respiratory Immunology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia;
2. Faculty of Medicine and
3. Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, Massachusetts;
4. The Pulmonary Center, Department of Medicine, School of Medicine, Boston University, Boston, Massachusetts;
5. Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland;
6. Center for Bacterial Pathogenesis, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts;
7. Department of Microbiology, Blavatnik Institute, Harvard Medical School, Harvard University, Boston, Massachusetts;
8. Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria;
9. School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia;
10. Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, Queensland, Australia;
11. Immunopathology Group, Mater Research Institute–University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia;
12. Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania, Australia;
13. Department of Respiratory Medicine, Mater Adult Hospital, South Brisbane, Queensland, Australia;
14. Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, Institut National de la Santé et de la Recherche Médicale, and Université Toulouse III–Paul Sabatier, Toulouse, France; and
15. Institute of Interdisciplinary Research, Free University of Brussels, Gosselies, Belgium